Liewluck Teerin, Saperstein David S
Department of Neurology, University of Colorado School of Medicine, Anschutz Medical Campus, 12631 East 17th Avenue, Mail Stop B-185, Aurora, CO 80045, USA; Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Phoenix Neurological Associates, University of Arizona College of Medicine, 5090 North 40th Street, Suite 250, Phoenix, AZ 85018, USA.
Neurol Clin. 2015 Nov;33(4):761-73. doi: 10.1016/j.ncl.2015.07.005.
Progressive muscular atrophy (PMA) is a rare, sporadic, adult-onset motor neuron disease, clinically characterized by isolated lower motor neuron features; however, clinically evident upper motor neuron signs may emerge in some patients. Subclinical upper motor neuron involvement is identified pathologically, radiologically, and neurophysiologically in a substantial number of patients with PMA. Patients with subclinical upper motor neuron involvement do not fulfill the revised El Escorial criteria to participate in amyotrophic lateral sclerosis clinical trials. Intravenous immunoglobulin therapy is only marginally beneficial in a small subgroup of patients with lower motor neuron syndrome without conduction block.
进行性肌肉萎缩(PMA)是一种罕见的、散发性的、成人起病的运动神经元疾病,临床特征为单纯的下运动神经元表现;然而,部分患者可能会出现临床上明显的上运动神经元体征。在大量PMA患者中,通过病理、放射学及神经生理学检查可发现亚临床的上运动神经元受累情况。存在亚临床上运动神经元受累的患者不符合修订后的埃斯科里亚尔标准,无法参与肌萎缩侧索硬化症的临床试验。静脉注射免疫球蛋白治疗仅对一小部分无传导阻滞的下运动神经元综合征患者有轻微益处。